ALT Trends through Childhood and Adolescence Associated with Hepatic Steatosis at 24 Years: A Population-Based UK Cohort Study

(1) Background: Alanine aminotransferase (ALT) is used to screen for non-alcoholic fatty liver disease (NAFLD) in children; however, the optimal age to commence screening is not determined. Our objective was to describe whether ALT trends from 9-24 years were associated with hepatic steatosis at 24...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahlia Sekkarie (Author), Jean A. Welsh (Author), Kate Northstone (Author), Catherine E. Cioffi (Author), Aryeh D. Stein (Author), Janet Figueroa (Author), Usha Ramakrishnan (Author), Miriam B. Vos (Author)
Format: Book
Published: MDPI AG, 2020-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_4a4085c9de314f8288f55720b0c7bb18
042 |a dc 
100 1 0 |a Ahlia Sekkarie  |e author 
700 1 0 |a Jean A. Welsh  |e author 
700 1 0 |a Kate Northstone  |e author 
700 1 0 |a Catherine E. Cioffi  |e author 
700 1 0 |a Aryeh D. Stein  |e author 
700 1 0 |a Janet Figueroa  |e author 
700 1 0 |a Usha Ramakrishnan  |e author 
700 1 0 |a Miriam B. Vos  |e author 
245 0 0 |a ALT Trends through Childhood and Adolescence Associated with Hepatic Steatosis at 24 Years: A Population-Based UK Cohort Study 
260 |b MDPI AG,   |c 2020-09-01T00:00:00Z. 
500 |a 10.3390/children7090117 
500 |a 2227-9067 
520 |a (1) Background: Alanine aminotransferase (ALT) is used to screen for non-alcoholic fatty liver disease (NAFLD) in children; however, the optimal age to commence screening is not determined. Our objective was to describe whether ALT trends from 9-24 years were associated with hepatic steatosis at 24 years in a population-based UK cohort. (2) Methods: The sample included 1156 participants who were assessed for hepatic steatosis at 24 years and had at least two ALT measurements at 9, 15, 17, and/or 24 years. Controlled attenuation parameter scores were used to assess steatosis (low (<248 dB/m), mild/moderate (248-279 dB/m), severe (>279 dB/m)). Sex-stratified mixed-effects models were constructed to assess the liver enzyme trends by steatosis level. (3) Results: The final sample was 41.4% male and 10.4% had severe steatosis. In both sexes, ALT trends from 9 to 24 years differed in those with low vs. severe steatosis at 24 years (<i>p</i> < 0.001). There was no evidence of differences prior to puberty. At 17 years, the low vs. severe geometric mean ratio (GMR) was 0.69, 95% CI: 0.57-0.85 in males and (0.81, 0.65-1.01) females. At 24 years, the GMR was (0.53, 0.42-0.66) in males and (0.67, 0.54-0.84) females. (4) Conclusions: Higher ALT concentration in adolescence was associated with hepatic steatosis at 24 years. The increased screening of adolescents could strengthen NAFLD prevention and treatment efforts. 
546 |a EN 
690 |a NAFLD 
690 |a ALT 
690 |a childhood 
690 |a longitudinal 
690 |a ALSPAC 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Children, Vol 7, Iss 9, p 117 (2020) 
787 0 |n https://www.mdpi.com/2227-9067/7/9/117 
787 0 |n https://doaj.org/toc/2227-9067 
856 4 1 |u https://doaj.org/article/4a4085c9de314f8288f55720b0c7bb18  |z Connect to this object online.